Search Login Register

Lysophosphatidylcholines (Lysophosphatidylcholine) Summary

Description: Derivatives of PHOSPHATIDYLCHOLINES obtained by their partial hydrolysis which removes one of the fatty acid moieties.

Also Known As: Lysophosphatidylcholine; Lysolecithins

Networked: 492 relevant articles (18 outcomes, 39 trials/studies) for this Bio-Agent

Key Diseases for which Lysophosphatidylcholines is Relevant

  1. Atherosclerosis : 3 outcomes 5 studies in 64 results
  2. Cardiac Arrhythmias (Arrythmia) : 2 outcomes 2 studies in 16 results
  3. Sepsis (Septicemia) : 2 outcomes 2 studies in 11 results
  4. Demyelinating Diseases (Demyelinating Disease) : 1 outcome 5 studies in 34 results
  5. Ischemia : 1 outcome 4 studies in 48 results
Show All >>

Drugs Related to Lysophosphatidylcholines

  1. Nonesterified Fatty Acids (NEFA)
  2. Cholesterol
  3. Phosphatidylcholines (Phosphatidylcholine)
  4. Phospholipases A2 (Phospholipase A2)
  5. 1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)
  6. Carnitine (L-Carnitine)
  7. Cholesterol Esters (Cholesteryl Esters)
  8. Ethyl Ether (Ether)
  9. Isoproterenol (Isoprenaline)
  10. Tretinoin (Retinoic Acid)
Show All >>

Therapies Related to Lysophosphatidylcholines

  1. Heterologous Transplantation (Xenotransplantation)
  2. Spinal Injections
  3. Resuscitation
  4. Intravenous Injections
  5. Injections
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.